Eledon Pharmaceuticals, Inc. (ELDN) Net income 2016–2025
Eledon Pharmaceuticals, Inc. (ELDN) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$45.6MFY2025 · since FY2016: -$5.7M → -$45.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$45.6M | -26.1% |
| FY2024 | -$36.2M | +69.0% |
| FY2023 | -$116.5M | -32.5% |
| FY2022 | -$88.0M | -154.9% |
| FY2021 | -$34.5M | -51.3% |
| FY2020 | -$22.8M | -42.5% |
| FY2019 | -$16.0M | -13.8% |
| FY2018 | -$14.1M | -7.2% |
| FY2017 | -$13.1M | -131.9% |
| FY2016 | -$5.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ELDN financial trends
ELDN RevenueELDN Net marginELDN Gross profitELDN Gross marginELDN Operating incomeELDN Operating marginELDN Operating cash flowELDN Free cash flowELDN Capital expendituresELDN Return on equityELDN Stock buybacksELDN Dividends paidELDN Total assetsELDN Total liabilitiesELDN Shareholders’ equityELDN overview →